Lexaria Bioscience Corp. Operating Income Loss

• Lexaria Bioscience Corp. showed a decrease of -106.5% in Operating Income Loss from 2024 to 2025.
• This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
• XBRL data for this metric is available from 2014 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2014 to 2025), Lexaria Bioscience Corp.'s Operating Income Loss has declined by 661.9%.
• Historical annual values: Fiscal year 2025: -$11.88 million | Fiscal year 2024: -$5.75 million | Fiscal year 2023: -$6.53 million | Fiscal year 2022: -$6.62 million | Fiscal year 2021: -$5.69 million | Fiscal year 2016: -$1.28 million | Fiscal year 2015: -$1.98 million | Fiscal year 2014: -$1.56 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026